Bretylium potentiation of the contractor responses of isolated rabbit aortic strips to potassium and tyramine

1 Pretreatment of rabbit aortic strips with bretylium potentiated the contractor response to potassium and tyramine but not to noradrenaline. On the other hand, such pretreatment inhibited the response to nicotine. 2 Even in reserpinized or cold stored aortic strips, pretreatment with bretylium enhanced the contractor response to potassium and tyramine. 3 Pretreatment of fresh, reserpinized, or cold stored aortic strips with pheniprazine potentiated the contractor response to potassium and tyramine. 4 Pretreatment of aortic strips with bretylium or pheniprazine did not potentiate the response to 5‐hydroxytryptamine (5‐HT). 5 The results indicate that both bretylium and pheniprazine potentiate the action of tyramine and potassium, not by presynaptic mechanisms, but by postsynaptic action, causing an increase in the sensitivity of the effector cells to the stimulants.

[1]  A. Boura,et al.  THE ACTIONS OF BRETYLIUM: ADRENERGIC NEURONE BLOCKING AND OTHER EFFECTS , 1997, British journal of pharmacology and chemotherapy.

[2]  A. Diosy Monoamine oxidase inhibitors , 1984 .

[3]  S. Shibata,et al.  Adrenergic innervation and cocaine-induced potentiation of adrenergic responses of aortic strips from young and old rabbits. , 1971, The Journal of pharmacology and experimental therapeutics.

[4]  S. Shibata Effect of Prolonged Cold Storage on the Contractile Response of Strips of Rabbit Aorta to Various Agents , 1969, Circulation research.

[5]  S. Shibata,et al.  Effect of tranylcypromine on the mechanical activity of rabbit aorta and esophagus and guinea pig taenia coli. , 1969, European Journal of Pharmacology.

[6]  D. Clarke,et al.  The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat. , 1968, British journal of pharmacology and chemotherapy.

[7]  F. Jané,et al.  Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens , 1968, The Journal of pharmacy and pharmacology.

[8]  M. Rand,et al.  The actions of some adrenergic neurone blocking drugs at cholinergic junctions. , 1967, European journal of pharmacology.

[9]  A. Carlsson,et al.  The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine‐treated mice , 1967, The Journal of pharmacy and pharmacology.

[10]  P. Spano Potentiation of the noradrenaline‐releasing action of tyramine by monoamine oxidase inhibitors , 1966, The Journal of pharmacy and pharmacology.

[11]  F. Sjöqvist,et al.  Psychotropic Drugs (2) Interaction between Monoamine Oxidase (MAO) Inhibitors and other Substances , 1965, Proceedings of the Royal Society of Medicine.

[12]  L. I. Goldberg,et al.  MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS. , 1964, JAMA.

[13]  R. Gillis,et al.  RESERPINE AS AN ANTAGONIST OF TYRAMINE. , 1964, The Journal of pharmacology and experimental therapeutics.

[14]  B. Bhagat MODIFICATION OF THE EFFECTS OF GUANETHIDINE ON CARDIAC CATECHOL AMINES BY VARIOUS AGENTS. , 1964, British journal of pharmacology and chemotherapy.

[15]  R. Furchgott,et al.  ACTIONS AND INTERACTIONS OF NOREPINEPHRINE, TYRAMINE AND COCAINE ON AORTIC STRIPS OF RABBIT AND LEFT ATRIA OF GUINEA PIG AND CAT. , 1963, The Journal of pharmacology and experimental therapeutics.

[16]  R. Kuntzman,et al.  MONOAMINE OXIDASE INHIBITION BY A SERIES OF COMPOUNDS STRUCTURALLY RELATED TO BRETYLIUM AND GUANETHIDINE. , 1963, Journal of Pharmacology and Experimental Therapeutics.

[17]  D. Dvornik,et al.  The effect of some inhibitors of the postganglionic sympathetic mechanism on monoamine oxidase , 1963 .

[18]  A. Boura,et al.  Adrenergic neurone blockade and other acute effects caused by N-benzyl-N'N"-dimethylguanidine and its ortho-chloro derivative. , 1963, British journal of pharmacology and chemotherapy.

[19]  A. Mccoubrey BIOCHEMICAL PROPERTIES OF BRETYLIUM , 1962 .

[20]  R. Ryall Effects of cocaine and antidepressant drugs on the nictitating membrane of the cat. , 1961, British journal of pharmacology and chemotherapy.

[21]  H. Kosterlitz,et al.  Action of bretylium on the isolated guinea-pig ileum. , 1961, British journal of pharmacology and chemotherapy.

[22]  O. Gulati,et al.  Potentiation of inhibitory and excitatory effects of catechol amines by bretylium. , 1961, British journal of pharmacology and chemotherapy.

[23]  A. Sjoerdsma,et al.  Effects of several monoamine oxidase inhibitors on the cardiovascular actions of naturally occurring amines in the dog. , 1959, The Journal of pharmacology and experimental therapeutics.

[24]  M. Rand,et al.  The action of sympathomimetic amines in animals treated with reserpine , 1958, The Journal of physiology.

[25]  M. Rand,et al.  Noradrenaline in Artery Walls and its Dispersal by Reserpine , 1958, British medical journal.

[26]  S. Corne,et al.  The effect of inhibition of amine oxidase in vivo on administered adrenaline, noradrenaline, tyramine and serotonin , 1957, The Journal of physiology.

[27]  S. R. Kottegoda,et al.  The action of nicotine and acetylcholine on the vessels of the rabbit's ear. , 1953, British journal of pharmacology and chemotherapy.

[28]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[29]  C. Bell Differential effects of tetrodotoxin on sympathomimetic actions of nicotine and tyramine. , 1968, British journal of pharmacology and chemotherapy.

[30]  P. A. Shore,et al.  Monoamine oxidase inhibition in the adrenergic neuron by bretylium, debrisoquin, and other adrenergic neuronal blocking agents , 1967 .

[31]  R. Furchgott,et al.  THE SYMPATHOMIMETIC ACTION OF BRETYLIUM OF ISOLATED ATRIA AND AORTIC SMOOTH MUSCLE. , 1964, Journal of Pharmacology and Experimental Therapeutics.